DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale’s Corcept Therapeutics CORT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$294K	Hold	7,360	–	–	﹤0.01%	937
2025 Q4	$191K	Hold	7,360	–	–	﹤0.01%	1153
2025 Q3	$611K	Hold	7,360	–	–	﹤0.01%	952
2025 Q2	$542K	Hold	7,360	–	–	﹤0.01%	969
2025 Q1	$391K	Hold	7,360	–	–	﹤0.01%	1007
2024 Q4	$386K	Hold	7,360	–	–	﹤0.01%	1045
2024 Q3	$319K	Hold	7,360	–	–	﹤0.01%	1087
2024 Q2	$234K	Hold	7,360	–	–	﹤0.01%	1133
2024 Q1	$184K	Hold	7,360	–	–	﹤0.01%	1169
2023 Q4	$241K	Hold	7,360	–	–	﹤0.01%	1167
2023 Q3	$242K	Buy	+7,360	New	+$213K	﹤0.01%	1156

Other funds holding CORT

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return